It has been reported that miR-26a is able to inhibit the expression of HMGA2 in gallbladder cancer and non-small cell lung cancer, and upregulate PTEN expression in gastric cancer37–39. This evidence concerns the gene HMGA2 and non-small cell lung carcinoma.